NSE filing, NSE: AMBUJACEM. Summary written from the filing by ALFA Finder's alert engine.
Ambuja Cements Ltd: key numbers
- Share price
- ₹368.90
- Market cap
- ₹91,186 Cr
- Revenue (annual)
- ₹40,656 Cr
- Net profit (annual)
- ₹4,728 Cr
- P/E (TTM)
- 32.5×Sector 33.1×
- Promoter holding
- 67.33%+0.00% QoQ
- FII holding
- 5.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ambuja Cements Ltd
All →Ambuja Cements Capacity Expansion: ₹14,500 Cr Investment
Ambuja Cements announces ~30 MTPA cement expansion with ₹14,500 Crore capex. Capacity will reach 155 MTPA by FY30 from current 113.5 MTPA.
- Value
- ₹14,500 Cr
- Execution
- through FY30
- new cement capacity (grinding + clinker)
- 30.0 MTPA
Ambuja Cements Earnings Call Transcript: Key Takeaways
Ambuja delivers a resilient volume-led quarter despite monsoon headwinds, pivoting toward aggressive capacity expansion to 155 MTPA by FY30 while maintaining cost leadership.
Ambuja Cements Acquisition Worth ₹33.75 Cr
Ambuja Cements will acquire 26% of SWE Renewables for ₹33.75 Crore over 15 months. The move targets wind-powered captive electricity to reduce grid dependence.
- Value
- ₹33.75 Cr
- Execution
- 15 months (in one or more tranches)
Ambuja Cements Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹9,197 Cr, flat YoY. EBITDA ₹1,271 Cr (-28%), margin 13.8% (vs 19.2%). Reported PAT ₹236 Cr (-90%). Company remains debt-free.
Ambuja Cements Results Update
Ambuja Cements posted Q2 FY27 consolidated revenue of Rs 9,197 Cr with EBITDA of Rs 1,271 Cr. The firm commissioned 4.6 MTPA of new capacity amid headwinds.
- cement manufacturing capacity
- 4.6 MTPA
Ambuja Cements Q2 FY27 Results: Net Profit ₹236 Cr, Down 89.9% YoY
Ambuja Cements Ltd reported revenue from operations of ₹9,197 Cr (+0.2% YoY) and net profit of ₹236 Cr (-89.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹236 Cr · -89.9% YoY
Other dividend announcements
All →Bayer Cropscience Dividend
Bayer CropScience declared an interim dividend of Rs. 90 per equity share for FY 2026-27 on November 3, 2026. Record date is November 12, 2026 and payment is due November 30, 2026.
Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
BMW Ventures Dividend
BMW Ventures declared an interim dividend of Rs 1.5 per equity share for 2026-27. Record date is 13 November 2026, with payment by 2 December 2026.
Remus Pharmaceuticals Dividend
Remus Pharmaceuticals has fixed 7 November 2026 as the record date for its 1st interim dividend for FY 2026-27, declared at today's board meeting. The filing does not state the per-share dividend amount.
Mobavenue AI Tech Dividend
Mobavenue AI Tech Ltd has declared an interim dividend of ₹0.10 per equity share for FY 2026-27. The company fixed November 13, 2026, as the record date for payment.
TAAL Tech Dividend
TAAL Tech declared an interim dividend of Rs 5 per share for 2026-27. Record date is 13 November 2026 with payment by 2 December.